Clinical Trials Logo

Comatose clinical trials

View clinical trials related to Comatose.

Filter by:
  • None
  • Page 1

NCT ID: NCT04798508 Recruiting - Clinical trials for Neurophysiologic Abnormality

EXPRE-SON-REA : Expressive Own Names in Neurophysiologic Assessment of Comatose Patients

EXPRESONREA
Start date: July 30, 2020
Phase: N/A
Study type: Interventional

Evaluating the neurologic prognosis in disorders of consciousness (DOC) patients is still a crucial issue in intensive care units. Neurophysiology allows the investigators to record cerebral responses of patients to auditory stimuli and in particularly to their own name. Numerous studies try to improve the relevance of the auditory stimuli used in this paradigm. Here the investigators assess if the use of own name stimuli uttered by more expressive voices (for example smiling voices) modulates the cerebral responses recorded. They then correlate these cerebral responses to the neurologic prognosis at three months.

NCT ID: NCT04653597 Completed - Poisoning Clinical Trials

Non-invasive Airway Management of Comatose Poisoned Emergency Patients

NICO
Start date: May 16, 2021
Phase: Phase 3
Study type: Interventional

A decreased level of consciousness is a common reason for presentation to the emergency department (ED) and is often the result of intoxication (up to 1% of all ED visits and 3% of ICU admission). In France, approximately 165 000 poisoned patients are managed each year. Originally developed in head injured patients, the Glasgow Coma Scale (GCS) is a validated reproducible score evaluating the level of consciousness: a GCS ≤ 8 is strongly associated with reduced gag reflex and increased incidence of aspiration pneumonia. Although recommended for patients with traumatic brain injury and coma, it remains unknown whether the benefit of an invasive management of airways with sedation, intubation and mechanical ventilation should be applied to other causes of coma in particular for acute poisoned patients. The investigator hypothesize that a conservative management with close monitoring without immediate endotracheal intubation of these patients is effective and associated with less in-hospital complications (truncated at 28 days) compared to routine practice management (in which the decision of immediate intubation is left to the discretion of the emergency physician).

NCT ID: NCT02607878 Completed - Cardiac Arrest Clinical Trials

Automated Pupillometry for Coma Prognostication After Cardiac Arrest

Start date: January 2015
Phase:
Study type: Observational

Background: Sedation and therapeutic hypothermia (TH) delay neurological responses and might reduce the accuracy of clinical examination to predict outcome after cardiac arrest (CA). Electroencephalography (EEG) and somato-sensory evoked potentials (SSEP) might significantly improve prognostication of post-CA coma, however, EEG and SSEP are not always available and require specific expertise for their interpretation. Automated video pupillometry is a novel electronic device that contains an infrared light camera which enables to measure quantitatively the percentage of pupillary reaction to a calibrated light stimulation. In a recent study of a cohort of comatose CA survivors (n=50 patients) it was found that quantitative PLR was more accurate than standard PLR (manual pen light) in predicting 3-month outcome, irrespective of temperature and sedation, and had comparable prognostic accuracy than electrophysiological exams, including electroencephalography (EEG) and somato-sensory evoked potentials (SSEP). Aim of the study: In light of these promising results, the investigators would like to confirm the prognostic value of quantitative PLR in a large multicenter cohort of comatose post-CA patients. Design of the study: Prospective, multicenter, observational outcome trial.

NCT ID: NCT02175875 Completed - Comatose Clinical Trials

Ticagrelor for the Comatose

TICOMA
Start date: September 2014
Phase: N/A
Study type: Observational

The study will investigate the effect of the oral antiplatelet agent ticagrelor (Brilique) when it is administrated through a nasogastric tube in comatose patients. The platelet function can be determined by various platelet function tests (PFT), Multiplate and VerifyNow . As control, the reference intervals from the literature are used. Futhermore, plasma concentrations of the active metabolite will be determined at aeveral timepoints after first intake of a bolus dose.

NCT ID: NCT00384319 Completed - Cardiac Arrest Clinical Trials

Pilot Clinical Study of the LRS ThermoSuitâ„¢ System in Post Arrest Patients

Start date: October 2006
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine if the Life Recovery Systems Thermosuit(R) System is able to quickly and conveniently cool patients who are comatose after resuscitation from cardiac arrest.